A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Coronaviruses are a genetically diverse family of viruses that infect birds and mammals, with most coronavirus strains limited to infecting only certain hosts. Human coronaviruses, for example, cause up to 30 percent of common colds.
In the last 15 years, however, coronaviruses have demonstrated their ability to jump into new species. Zoonotic (animal) coronaviruses have infected humans, causing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), severe diseases with high mortality rates ranging from 10 percent for SARS to 40 percent for MERS. The MERS-coronavirus continues to cause new infections in the Middle East.
“There’s a real concern that the MERS coronavirus could escape broadly when millions of people visit Saudi Arabia for the Hajj,” said Mark Denison, M.D., Craig-Weaver Professor of Pediatrics and professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine.
But to date, there has been no effective antiviral drug for any known coronavirus, Denison noted.
Denison and his team at Vanderbilt have studied the basic biology of coronaviruses for more than 20 years. In an effort to find chemical tools that would allow them to probe viral replication, graduate student Brett Case screened a series of compounds selected and provided by Gilead Sciences.
Case demonstrated that one of the compounds was highly active against coronaviruses in cultured cells. The finding was a surprise, Denison said, because compounds in the same class (nucleoside analogs) have normally failed to inhibit coronavirus replication.
The compound, called GS-5734, is currently in clinical development for treatment of Ebola virus disease.
Denison’s longtime collaborator Ralph Baric, Ph.D., at the University of North Carolina and his team demonstrated that GS-5734 inhibits SARS-coronavirus and MERS-coronavirus replication in multiple in vitro systems, including cultures of primary human airway epithelial cells, which are the cells infected by respiratory coronaviruses.
The researchers also showed that GS-5734 was effective against a circulating human coronavirus, bat coronaviruses, and bat coronaviruses that are considered “prepandemic” because they can infect cultured human cells.
Using a mouse model of SARS, the investigators demonstrated that both prophylactic (before infection) and early therapeutic (soon after infection) administration of GS-5734 reduced viral load in the lungs and improved respiratory functions.
“This compound shows broad activity against a variety of human and animal coronaviruses and represents an exciting potential therapeutic for a family of viruses prone to emergence from animal reservoirs,” Denison said.
Denison and his team at Vanderbilt will continue to use the compound “as a probe to try to understand the biology of the virus, how and why this drug works, and to identify new targets for inhibiting coronaviruses,” he said.
“This is an exciting example of how pursuing fundamental research to understand the mechanisms of virus replication and pathogenesis can lead to an important compound with therapeutic potential.”
The Latest on: Coronaviruses
[google_news title=”” keyword=”coronaviruses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Experts Reveal Exactly What You Should Eat When You Have COVID-19on February 27, 2024 at 3:57 pm
your immune system strong overnight, but consuming nutrient-dense foods over time plays a big role.” Focus on fiber-rich foods like whole grains, add fruits and vegetables whenever possible, include ...
- Tarrant County had a ‘disjointed’ response to COVID-19 emergency, report concludeson February 27, 2024 at 2:12 pm
Tarrant County’s response to the COVID-19 pandemic was often “disjointed,” with poor communication and officials failing to follow established emergency plans, according to an external review of the ...
- Study Largely Confirms Known, Rare COVID-19 Vaccine Side Effectson February 27, 2024 at 1:08 pm
An international study of around 99 million people confirmed known serious side effects of COVID-19 vaccination. It also identified a possible relationship between the first dose of the Moderna ...
- CDC director Mandy Cohen talks about lessons from their response to the COVID-19 pandemicon February 27, 2024 at 1:01 pm
Mandy Cohen, director of the Centers for Disease Control and Prevention, talks about their role in public health and lessons from the pandemic.
- Joe Kanter, top Louisiana health official who led COVID-19 response, steps downon February 27, 2024 at 12:14 pm
Dr. Joe Kanter, an emergency room physician who served as one of Louisiana’s top medical officials through the COVID-19 pandemic, has stepped down from his position, Kanter confirmed Tuesday.
- New research describes the patterns of COVID-19 outbreaks in Scotland's care homes, beyond the first wave of infectionson February 27, 2024 at 12:07 pm
A study, undertaken by the University of Glasgow in partnership with the Advanced Care Research Center, University of Edinburgh, has demonstrated the severe effects of COVID-19 on people living in ...
- Halifax's fitness industry has rebounded from COVID-19 lockdownson February 27, 2024 at 11:29 am
When she begins a yoga class at her north-end Halifax studio, Tori Jarvis Grant still sets up a camera so students can follow along at home with those attending in person.It's a holdover from the ...
- From COVID-19 to Measles, Florida’s War on Public Healthon February 27, 2024 at 9:27 am
Measles is a very contagious virus, 5 to 10 times more contagious than COVID-19, as it travels long distances and lingers in the air for hours. If an unvaccinated individual is exposed, there is a ...
- Healthy runner's stroke followed a bad bout of COVID-19on February 27, 2024 at 7:32 am
The carotid arteries in the neck are major blood vessels for the brain. One of Marshall's was almost completely blocked in two places. She also had a carotid artery dissection, which is a tear of the ...
- Do you still have to isolate if you get COVID-19? Here are the 2024 CDC, local guidelineson February 27, 2024 at 5:15 am
The CDC advises following isolation guidelines for COVID-19, including a 5-day quarantine. These are the guidelines from the Arizona Health Department ...
via Google News and Bing News